Testing effectiveness (Phase 2)WithdrawnNCT04648826
What this trial is testing
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies
Who this might be right for
SarcomasMelanomasGerm Cell Tumors+2 more
National Cancer Institute (NCI)